Answers are grounded in this paper and cite their sources.
Background: Transbronchial lung biopsy is routinely performed to identify acute cellular rejection (ACR) in lung transplant recipients (LTRs). This trial evaluates the clinical value of forceps and cryobiopsies versus cryobiopsies as a standalone diagnostic tool. Methods: In this randomized trial, LTRs were randomly assigned to receive either 2 cryobiopsies (cryobiopsy group) or a combination of 5 forceps- and 2 cryobiopsies (combined group). The primary outcome was the diagnostic yield to detect ACR; the secondary outcome was the incidence of ACR. We conducted a paired, intraindividual comparison in the combined group alongside interindividual comparisons. The pneumothorax rate was overall 1.7%. There were no deaths or occurrences of severe bleeding. Conclusions: Cryobiopsies did not detect lower ACR than the combined group and can be used as primary and standalone diagnostic tools for histologic assessment of ACR without requiring forceps biopsies.
No takes yet. Share an insight, caveat, or question.
Steinack et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: